FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

771596001: Tezacaftor (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3706939018 Tezacaftor (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3706940016 Tezacaftor en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tezacaftor Is a Dioxole true Inferred relationship Existential restriction modifier
Tezacaftor Has disposition Cystic fibrosis transmembrane conductance regulator potentiator true Inferred relationship Existential restriction modifier
Tezacaftor Is a Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action true Inferred relationship Existential restriction modifier
Tezacaftor Is a Respiratory system agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ivacaftor and tezacaftor (medicinal product) Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Product containing ivacaftor and tezacaftor in oral dose form (medicinal product form) Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Tezacaftor + Ivacaftor Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Product containing only ivacaftor and tezacaftor in oral dose form (medicinal product form) Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Product containing elexacaftor and ivacaftor and tezacaftor (medicinal product) Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Product containing elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Ivacaftor + Tezacaftor + Elexacaftor Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) Has active ingredient True Tezacaftor Inferred relationship Existential restriction modifier 2
Generic Kaftrio 37.5mg/25mg/50mg tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Generic Kaftrio 37.5mg/25mg/50mg tablets 56 tablet Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Generic Kaftrio 75mg/50mg/100mg tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Generic Kaftrio 75mg/50mg/100mg tablets 56 tablet Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Tezacaftor 50mg / Ivacaftor 75mg tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Tezacaftor 50mg / Ivacaftor 75mg tablets 28 tablet Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Tezacaftor 100mg / Ivacaftor 150mg tablets 28 tablet Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Tezacaftor 100mg / Ivacaftor 150mg tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier
Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient True Tezacaftor Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start